Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dihydrophaseic acid 3'-O-b-D-glucopyranoside (D3G) can increase the proliferation and differentiation of osteoblast cells and enhance bone formation, suggests that D3G may be a good candidate for the treatment of osteoporosis.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約10-14 週間 | ¥ 727,500 |
50 mg | 約10-14 週間 | ¥ 959,500 |
100 mg | 約10-14 週間 | ¥ 1,331,500 |
分子量 | 282.33 |
分子式 | C15H22O5 |
CAS No. | 41756-77-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dihydrophaseic acid 41756-77-8 Others Inhibitor inhibitor inhibit